RxDoctor Payments Data

Amy Garrison

Adult Health · Lake Placid, NYNPI 1902155880

Payments from drug & device makers

$1,605in general payments, 2019–2025

Across 72 payments — averaging $22.30 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$379
  • AstraZeneca$279
  • Lilly USA, LLC$170
  • AbbVie$161
  • GSK$116
  • Astellas Pharma US Inc$101
  • plus $398 from 8 others

What the payments were for

  • Food & beverage$1,605100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,605 in reported general payments places this provider in the 75th percentile of 3,828 adult health providers in New York.

See all adult health providers in New York

Medicare billing

Part B allowed, 2024
$47,381
Medicare patients
282
Services billed
754

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban56$69,092
OzempicSemaglutide56$61,981
Tresiba Flextouch U-200Insulin Degludec29$38,096
MounjaroTirzepatide31$37,507
FarxigaDapagliflozin Propanediol26$36,490
XareltoRivaroxaban23$30,492
TrulicityDulaglutide21$19,071
WegovySemaglutide14$18,514
JardianceEmpagliflozin21$17,700
Anoro ElliptaUmeclidinium Brm/Vilanterol Tr16$9,629
Tresiba Flextouch U-100Insulin Degludec18$8,604
Incruse ElliptaUmeclidinium Bromide17$7,762
SymbicortBudesonide/Formoterol Fumarate18$6,689
Breo ElliptaFluticasone/Vilanterol12$4,634
Albuterol Sulfate HfaAlbuterol Sulfate107$4,515

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic, Wegovy$379$80,49570 claims
PfizerEliquis$19$69,09256 claims
Lilly USA, LLCMounjaro, Trulicity$170$56,57752 claims
AstraZenecaFarxiga, Symbicort$279$43,17944 claims
GSKAnoro Ellipta, Incruse Ellipta, Breo Ellipta$116$22,02545 claims
AbbVieSynthroid$161$1,30125 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 3,828 adult health providers in New York.

Other adult health in Lake Placid

See the full list for New York

Where these figures come from

Is this you, or does something look wrong? →